CoA without VSD

Date
August 2, 2025
URL
https://x.com/WithAScalpel/status/1951623647786832151
Categories
CoA

Coarctation of the Aorta without VSD

Coarctation of the aorta (CoA) without a ventricular septal defect presents an isolated LV pressure load, distinct from the pressure–volume double hit of CoA+VSD. Neonates may be duct-dependent, deteriorating as the ductus constricts; older patients develop proximal hypertension and distal hypoperfusion with time-dependent collateralization [1, 2].

Pathophysiology (refined)

  • Afterload & remodeling. Discrete arch obstruction increases LV afterload, producing concentric hypertrophy and reduced distal perfusion with metabolic acidosis and end-organ dysfunction in severe cases [2].
  • Neonatal ductal dependence. Right-to-left ductal flow may be essential for distal systemic perfusion; loss of this source precipitates cardiogenic shock, typically reversible with prostaglandin E₁ (PGE₁) until definitive repair [1].
  • Neurohormonal responses. Proximal hypertension and distal hypoperfusion activate RAAS, reinforcing vasoconstriction and sustaining systemic hypertension [2, 6].
  • Collateral formation (late). In older children/adults, intercostal and scapular collaterals partially bypass the lesion but predispose to aneurysm/vascular complications [6].

Clinical Presentation (clarified)

  • Neonates/infants. Poor feeding, tachypnea, metabolic acidosis, weak/absent femorals, and shock with ductal closure [1, 2].
  • Older children/adults. Upper-extremity hypertension with diminished leg pulses, leg claudication/exercise intolerance, headache or epistaxis; prolonged exposure risks LV hypertrophy, renal impairment, and cerebrovascular events [6].

Management Pathway

Acute stabilization.

  • Start PGE₁ to maintain ductal patency in duct-dependent neonates; add inotropes if LV dysfunction is present [1, 2].
  • Correct acidosis/anemia; avoid excessive afterload; monitor end-organ perfusion.

Definitive intervention (age/anatomy-based).

  • Neonates/infants: Surgical repair is preferred—most commonly extended end-to-end anastomosis, with patch aortoplasty reserved for selected anatomies [3].
  • Older children/adolescents/adults: Transcatheter therapy is favored; primary stent implantation is typically the procedure of choice in adequately sized aortas, with balloon angioplasty mainly for recoarctation or specific settings [4, 5].

Comparative outcomes.

  • Balloon angioplasty achieves similar immediate gradient relief to surgery but is associated with higher rates of recoarctation and aneurysm formation in many cohorts [4, 5].
  • Long-term issues after any modality include recoarctation, aortic aneurysm, and persistent systemic hypertension, mandating lifelong surveillance [6].

Post-repair Considerations

  • Paradoxical postoperative hypertension. Early sympathetic/RAAS-mediated hypertension is common after arch relief and may require short-term IV agents with transition to oral therapy; long-term BP control remains a key outcome target [6].
  • Follow-up. Serial BP profiling (arm/leg), imaging for arch dimensions and aneurysm surveillance, and exercise counseling are essential across the lifespan [6].

Summary

Isolated CoA imposes a pure pressure load on the LV, with duct-dependent shock risk in neonates and proximal hypertension/collateralization in delayed presentations. Management hinges on PGE₁-supported stabilization when needed, followed by surgery in infants and stent-based repair in larger patients, recognizing that recoarctation, aneurysm, and persistent hypertension drive the need for lifelong follow-up [1–6].

References

[1] Heymann MA. Prostaglandins and ductus-dependent congenital heart disease. Clin Perinatol. 1981;8(1):143-162.

[2] Fesseha AK, Eidem BW, O’Leary PW. Coarctation of the aorta in infants: pathophysiology and presentation. Prog Pediatr Cardiol. 2005;20(1):1-10.

[3] Egan MJ, Holzer RJ. Surgical management of native aortic coarctation in neonates and infants. Cardiol Young. 2009;19(3):247-254.

[4] Luijendijk P, Bouma BJ, Groenink M, et al. Stent implantation for native and recurrent coarctation: outcomes and complications. Catheter Cardiovasc Interv. 2012;80(4):663-670.

[5] Rodés-Cabau J, Miró J, Horlick E, et al. Surgery versus percutaneous therapy for native coarctation: a comparative analysis. Am Heart J. 2007;154(1):186-192.

[6] Vergales JE, Gangemi JJ, Rhueban KS, Lim DS. Long-term outcomes in repaired coarctation: recoarctation, aneurysm, and hypertension. Ann Pediatr Cardiol. 2013;6(2):153-158.